Effect of angiotensin II and α2 receptor antagonists on angiotensin II-stimulated nitric oxide release;Efecto de antagonistas de los receptores de angiotensina II y α2 adrenergicos sobre la liberación de oxido nitrico inducida por angiotenslna II

Medicina

Volumn 61, Issue 4, 2001, Pages 431-436

  Jerez, Susana ^a,b   De Bruno, Maria Peral ^a   Coviello, Alfredo ^a  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b NONE   (Argentina)

Author keywords

Angiotensisn II antagonists; Nitric oxide (NO); Yohimbine

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME RELEASE; HORMONAL REGULATION; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; RABBIT;

EID: 0034826643     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 1 receptors in endothelial cells. Br J Pharmacol 1996; 118: 79-84.
2. Webb ML, Dickinson KEJ, Delaney CL, Kiu ECK, Serafino R, Cohen RB, Monshizadegan H, Moreland S. The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta. Biochim Biophys Res Comm 1992; 185: 887-92.
3. Chen LH, McNeill JR, Wilson TW, Gopalakrishnan V. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II: role of endothelin. Hypertension 1995; 26: 83-8.
4. Lin L, Nasjletti A. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension 1991; 18: 158-64.
5. 2 contributes to the vasodepressor effects of baicalein in hypertensive rats. Hypertension 1998; 31: 866-71.
6. Zhang J, Pfaffendorf M, Zhang JS, Van Zwieten PA. Influence of the vascular endothelium on angiotensin II-induced contractions in rabbit renal artery. Fund Clin Pharmacol 1995; 9: 25-9.
7. Zhang J, Van Meel JCA, Pfaffendorf M, Zhang JS, Van Zwieten PA. Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta. Eur J Pharmacol 1994; 262: 247-53.
8. 1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 1995; 26: 752-7.
9. Pueyo ME. Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxinitrite in endothelial cells. Am J Physiol 1998; 274: C214-20.
10. Forstermann U, Neufang B. The endothelium-dependent relaxation of rabbit aorta: effects of antioxidants and hydroxylated eicosatetraenoic acids. Br J Pharmacol 1984; 82: 765-7.
11. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Progress in Cardiovascular Diseases 1995; 38: 105-28.
12. Kiowski W. Endothelial dysfunction in hypertension. Clin and Exper Hypertension 1999; 21: 635-46.
13. 2-adrenoceptors and endothelium-derived relaxing factor. Am J Med 1989; 87: 1S-5S.
14. Sheperd JT, Vanhcutte PM. Local modulation of adrenergic neurotransm ssion. Circulation 1981; 64:655-66.
15. Zimmerman BG, Kraft E. Blockade by saralasin of adrenergic potentiation induced by renin angiotensin system. J Pharmacol Exp Ther 1973; 210: 101-5.
16. Palaic D, Khairallah PA. Inhibition of noradrenaline uptake by angiotensin. J Pharm Pharmacol 1970; 22: 37-41.
17. Privat C, Lantoine F, Bedioui F, Millanvoye van Brussel E, Devynck J, Devynck MA. Nitric oxide production by endothelial cells: comparison of three methods of quantification. Life Sciences 1997; 61: 1193-202.
18. Seyedi N, Xu XB, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995; 26: 164-70.
19. Zhang X, Nasjletti A, Xu X, Hintze TH. Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism. J Cardiovasc Pharmacol 1998; 31: 623-9.
20. 1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries. J Am Soc Nephrol 1999; 10: 220-4.
21. Kai H, Fukui T, Lassegue B, Shah A, Minieri CA, Griendling KK. Prolonged exposure to agonists results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells. Mol Pharmacol 1996; 49, 96-104.
22. + and protein kinase C in angiotensin desensitization and tachyphylaxis in the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 1993; 347:425-31.
23. Guan H, Cachofeiro V, Pucci ML, Kaminski PM, Wolin MS, Nasjletti A. Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension 1996; 27:19-24.
24. 1 angiotensin receptors in spontaneously hypertensive rats. Clin Exp Hypertens 1997; 19:1247-61.
25. Cachofeiro V, Maeso R, Muñoz-García R, Lahera V. The potential role of nitric oxide in angiotensin II-receptor blockade. Blood Press Suppl 1996; 2:29-35.
26. Maeso R, Navarro-Cid J, Rodrigo E, Ruilope LM, Lahera V, Cachofeiro V. Differential effects of losartan and doxazosin on vascular function in senescent spontaneously hypertensive rats. Am J Hypertens 1999; 12:1105-8.
27. 2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett 1993; 3:24-7.
28. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 2000; 14:271-8.
29. Griendling KK, Minieri CA, Ollerenshaw R, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74:1141-48.